Companion Animal Drug Demand Intelligence

Discover, ingest, and analyze FDA animal-drug compounding documents, bulk drug substance nominations, and public docket comments to surface unmet medication needs in cats, dogs, and horses — and translate them into prioritized product-development opportunities.

Get started FDA Compounding Hub →

Automated FDA discovery

Crawl FDA.gov bulk-drug-substance lists, GFI #256, dockets, and Animal Drugs @ FDA. Detect cat/dog relevance automatically.

AI-drafted signal review

AI extracts structured compounding demand signals; analysts approve, edit, or reject before they feed downstream.

Ranked opportunities

Aggregate approved signals into prioritized product-development opportunities with full evidence traceability.

Regulatory & use guardrails

For R&D, market-intelligence, and product-development prioritization only.
Does not provide veterinary medical advice and does not recommend treatment.
Does not claim that compounded animal drugs are FDA-approved.
FDA states animal drugs compounded from bulk drug substances are not FDA-approved and have not been reviewed for safety, effectiveness, manufacturing quality, labeling, or packaging.